Meet us at SABCS 2020

We are delighted to be participating again in The San Antonio Breast Cancer Symposium taking place online this year 8-11 December.
Watch our video here>>
Email us at bd@cromospharma.com to set up a meeting.



Connect with Cromos Pharma at ASH Annual Meeting & Exposition 2020
Read our latest Insights@CromosPharma paper on Biosimilars
COVID-19 and its economic impacts have only strengthened the rationale for the development of a strong biosimilar market as health systems seek to reduce costs and make the most advanced treatments available to wider sections of the global population. At Cromos Pharma, we have extensive expertise in managing clinical trials for biosimilars.
Read the full paper here>>
Watch the video here>>
Clinical Trials in Georgia
This month we are putting the spotlight on Georgia as a prime location for your clinical trial. Despite its relatively small size Georgia boasts significant advantages for sponsors seeking to carry out new trials and also to increase enrollment in ongoing projects.
Read our Country Profile on Georgia here>>
Watch our video here>>
Cromos Pharma and Avance Clinical offer scalable clinical trial solution for biotech
This Euro-Australian collaboration allows biotechs to avail of Australia’s 43.5% tax rebate while benefiting from Central/Eastern Europe’s unbeatable recruitment rates for clinical trials.

Read our press release here>>
Watch the launch video here>>
Cromos Pharma provides tailored and effective clinical trial services to support the development of drugs that transform healthcare
Cromos™ Pharma is an international CRO, that specializes in managing global and regional Phase I-IV clinical trials. Find out more here>>
Wide geographical coverage that guarantees rapid enrollment
Cromos™ Pharma has a strong presence in the US, Eastern Europe (Bulgaria, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Poland, Romania and Slovakia) and post-soviet Europe (Armenia, Belarus, Geоrgia, Kazakhstan, Russia, Ukraine). Find out more here>>
No patients – No payments
Cromos Pharma has developed a unique risk-sharing program, where our clients pay only for enrolled patients, not for service hours! To learn more please watch this video>>

Our Key Differentiators

"No Patients - No Payments"
Rapid enrollment is supported by "NO PATIENTS – NO PAYMENTS” initiative which assures that Cromos Pharma is remunerated only for enrolled patients and not for dormant, non-recruiting sites.
Reliable feasibility and venue/site strategy
Our experienced feasibility team will swiftly prepare a detailed capability/feasibility report and will propose the optimal path forward, including country/venue strategy- and site-selection within the recommended venues.
CPR: Capability → Plan → Rescue
If your study is behind schedule or encounters difficulties with patient recruitment, Cromos Pharma will provide a comprehensive and collaborative rescue plan to ensure your investments yield a return and that your study meets its milestones and timelines.
Rapid patient recruitment and retention
By analyzing protocol design, study population, as well as sites’ motivation to enroll, subjects’ barriers to participation, and competing clinical programs, we developed a dynamic approach to identifying and resolving any issues related to subject recruitment and retention
Accelerated start-up
Our team of experts has years of experience working with the FDA/EMA and other agencies on the most complicated protocols. In the ex-US territories, favorable regulatory environment coupled with our in-depth local knowledge of submission guidelines and algorithms assures that your study is initiated as rapidly as it is humanly possible.
Patients First
The welfare of our patients is the utmost priority. We are fully compliant with ICH-GCP and make sure that patients in our studies are well-informed, and have a direct line of communication to both the investigators and to our research team.
Quality Management (Quality by Design)
Our Quality Management System is built upon Quality by Design principles that include integrated planning, quality agreements tailored to the project, real-time project risk-based analysis, data analytics-driven targeted monitoring, and customer-focused project optimization.

OUR Mission

At Cromos™ Pharma our philosophy is simple – our patients and clients come first. We strive to assist our partners in advancement of their clinical development programs that improve the lives of our patients. Since our establishment in 2004, we have fine-tuned our business model to reflect validated best practices from the most highly regulated venues, which we have carefully tailored to suit local environments. We are proud of our project managers, most with medical degrees, because they not only adhere flawlessly to study protocols, but appreciate the science behind them. read more

Vlad Bogin, MD, FACP CEO

Testimonials

Christelle J. Project Manager, Big Pharma
Today I just wanted to give you a little feedback after several months of working together. Just 2 words: "THANK YOU!!!"
For the time we have worked together, I notice the efforts to respond to any of... Read more
Isabelle D. Project Manager, Orphan drug company
I would like to thank Cromos team for their effort in completing study enrolment within our designated timelines in this complicated rare disease study!
Mark J. Director of Clinical Operations, Biotech
Based on my experience, Cromos Pharma's patient recruitment concept really works – Cromos rescued enrollment in my study in melanoma and I am pleased to say "Thanks" to all members of the team, especially... Read more
Mary N. Global Project Manager, Pharma
I would mention your CRAs Irena M. and Alex A. who did a great job, were very proactive and we got good feedback on their performance from the sites as well.
John M. Chief Executive Officer, Biotech
I have been impressed with the proactivity and the desire to get things done that has been shown by each one of the Cromos Pharma team with whom I have interacted. My experience with Cromos Pharma has certainly been... Read more
Marc T. Chief Medical Officer, Biotech
Thank you for wrapping up the study on time. I want to say that your team did an exceptional work and we would not hesitate to use Cromos again in our future studies. Great job!
Dalyana K. Clinical Operations Manager, Big Pharma
I would like to recognize Cromos Pharma's team for its outstanding work and to express my sincere gratitude.
Thank you for your help during the FDA inspection. You have displayed admirable characteristics... Read more
Irene C. Medical Affairs Manager, Mid-sized Pharma
I want to thank you for your work on the XXXX study. It is very important to our top management that we have met the timelines. I am sure that in many respects it is a credit to Helen S. I was touched by Helen’s... Read more
Joanne R. Project Manager, US-based CRO
It is a pleasure to work with all of you at Cromos Pharma, This is our largest project together and you have outperformed yourselves again. We just got a word from the sponsor that they are extremely pleased with both... Read more
Elena D. Project Manager, Pharma
I would like to extend my appreciation to the clinical team and medical writer who did a great job during close-out period of the study. This allowed us to perform all necessary procedures and collect all required... Read more
Nicola S. Clinical Trial Manager, Big Pharma
I would like to thank XXXX study team for concerted efforts during start-up and enrollment. Our study-wide enrollment target was achieved ahead of timelines and your country was the first which did it!!!
Lee M. Start-up Manager, Pharma
I was very impressed with the feasibility team, which managed to identify more than enough sites to enroll our study in a very rare pathology. And additional thanks for collecting all required documents from sites in... Read more